Free shipping on all orders over $ 500

PF-4136309

Cat. No. M20822

All AbMole products are for research use only, cannot be used for human consumption.

PF-4136309 Structure
Synonym:

INCB8761, PF-04136309

Size Price Availability Quantity
5mg USD 220  USD220 In stock
25mg USD 680  USD680 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

PF-4136309 (INCB8761, PF-04136309) is a potent, selective, and orally bioavailable CCR2 antagonist with an IC50 of 5.2 nM for human CCR2.

Chemical Information
Molecular Weight 568.59
Formula C29H31F3N6O3
CAS Number 857679-55-1
Solubility (25°C) DMSO 100 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Related CCR Products
JBH492

JBH492 is a first-in-class (C-C chemokine receptor 7) CCR7-targeting ADC, comprising a humanized, Fc-silenced anti-CCR7 IgG1 antibody conjugated to maytansinoid microtubule inhibitor DM4 via a cleavable linker.

CCR6 antagonist 1

CCR6 antagonist 1 is a CCR6 antagonist that inhibits the CCL20/CCR6 axis. CCR6 antagonist 1 can be used in the research of autoimmune-mediated inflammatory diseases, such as inflammatory bowel diseases (IBDs).

IPG7236

IPG7236 is a selective CCR8 antagonist that also exhibits significant tumor suppression in a mouse xenograft model of human breast cancer.IPG7236 can be used in cancer-related studies.

CKLF1-C19

CKLF1-C19 is the C-terminal peptide of human chemokine-like factor 1 (CKLF1).

Met-RANTES (human)

Met-RANTES (human) is a partial antagonist of CCR5.

  Catalog
Abmole Inhibitor Catalog




Keywords: PF-4136309, INCB8761, PF-04136309 supplier, CCR, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.